CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-03 | Waddill William D. Director | Option exercise · Stock Option (right to buy) | −12,000 | 0 | ||
| 2022-04-26 | Gupta Suneel Chief Development Officer | Option exercise | +40,000 | $7.38 | $295K | 117,561 |
| 2022-04-26 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −40,000 | 70,000 | ||
| 2022-04-26 | PATEL DINESH V PH D President and CEO | Option exercise | +30,000 | $4.21 | $126K | 568,306 |
| 2022-04-26 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −30,000 | 95,742 | ||
| 2022-04-18 | Ali Asif Chief Financial Officer | Grant or award | +13,750 | 13,750 | ||
| 2022-04-18 | Ali Asif Chief Financial Officer | Grant or award · Stock Option (right to buy) | +82,500 | 82,500 | ||
| 2022-04-14 | PATEL DINESH V PH D President and CEO | Option exercise | +34,087 | $1.89 | $64K | 537,847 |
| 2022-04-14 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −34,087 | 0 | ||
| 2022-02-28 | Gupta Suneel Chief Development Officer | Shares withheld for taxes | −649 | $24.28 | $16K | 77,007 |
| 2022-02-28 | PATEL DINESH V PH D President and CEO | Shares withheld for taxes | −4,648 | $24.28 | $113K | 503,760 |
| 2022-02-28 | Liu David Y Chief Scientific Officer | Shares withheld for taxes | −2,119 | $24.28 | $51K | 66,538 |
| 2022-02-15 | Kalkofen Donald A. Chief Financial Officer | Grant or award | +7,500 | 18,521 | ||
| 2022-02-15 | Kalkofen Donald A. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-02-15 | Liu David Y Chief Scientific Officer | Grant or award | +10,000 | 68,657 | ||
| 2022-02-15 | Liu David Y Chief Scientific Officer | Grant or award · Stock Option (right to buy) | −60,000 | 60,000 | ||
| 2022-02-15 | Gupta Suneel Chief Development Officer | Grant or award | +12,500 | 77,656 | ||
| 2022-02-15 | Gupta Suneel Chief Development Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2022-02-15 | PATEL DINESH V PH D President and CEO | Grant or award | +31,250 | 508,408 | ||
| 2022-02-15 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +187,500 | 187,500 |
Page 17 of 29 · 580 trades